SQZ BIOTECHNOLOGIES CO (SQZ)
US78472W1045 - Common Stock
| MRQ (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 39.87M | 63.71M | 143.51M | 170.40M | 39.30M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | 59.00M | |||
| Receivables | N/A | 384.00K | 3.10M | 2.40M | 2.10M | |||
| Other Current Assets | 4.58M | 4.11M | 4.03M | 4.00M | 1.50M | |||
| Total Current Assets | 44.45M | 68.20M | 150.63M | 176.80M | 101.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 26.40M | 29.39M | 72.89M | 52.00M | 48.20M | |||
| Other Non-Current Assets | 2.31M | 2.31M | 2.63M | 2.30M | 2.30M | |||
| Total Non-Current Assets | 28.71M | 31.70M | 75.52M | 54.30M | 50.60M | |||
| TOTAL ASSETS | 73.16M | 99.90M | 226.15M | 231.10M | 152.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 9.53M | 18.62M | 16.75M | 15.60M | 16.50M | |||
| Accounts Payable | 2.48M | 2.51M | 3.97M | 3.70M | 2.80M | |||
| Other Current Liabilities | 678.00K | 715.00K | 12.51M | 25.90M | 19.00M | |||
| Total Current Liabilities | 12.69M | 21.84M | 33.22M | 45.20M | 38.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 20.31M | 20.91M | 68.95M | 58.70M | 55.50M | |||
| Total Non-Current Liabilities | 20.31M | 20.91M | 68.95M | 58.70M | 55.50M | |||
| TOTAL LIABILITIES | 33.00M | 42.75M | 102.18M | 103.90M | 93.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -292.66M | -274.97M | -195.51M | -126.80M | -76.20M | |||
| Additional Paid In Capital | 332.79M | 332.09M | 319.46M | 253.90M | 2.70M | |||
| Common Shares | 29.00K | 29.00K | 28.00K | 0.00 | 132.10M | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | 0.00 | |||
| Shares Outstanding | 29.49M | 29.49M | 28.13M | 24.80M | 24.00M | |||
| Tangible Book Value per Share | 1.36 | 1.94 | 4.41 | 5.13 | -3.06 | |||
| Total Shareholders' Equity | 40.16M | 57.15M | 123.98M | 127.20M | 58.60M | |||
| TOTAL LIABILITIES AND EQUITY | 73.16M | 99.90M | 226.15M | 231.10M | 152.40M | |||
| Statistics | ||||||||
| Current Ratio | 3.50 | 3.12 | 4.53 | 3.91 | 2.66 | |||
| Return On Assets (ROA) | -104.04% | -79.54% | -30.40% | -21.86% | -21.13% | |||
| Return On Equity (ROE) | -189.54% | -139.05% | -55.45% | -39.72% | -54.95% | |||
All data in USD